You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements

ID: 3-3 May 2012
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
Authors:
N. Fleshner, N. Ivers, H. Lukka, B. Shayegan, C. Walker-Dilks, E. Winquist , Genitourinary Cancer Disease Site Group

Patient Population

Men older than or equal to 18 years of age who are being assessed and monitored for prostate cancer.

Intended Guideline Users

Urologists, oncologists specializing in genitourinary cancers, primary care practitioners, and the general public.

Research Question(s)

In patients without a diagnosis of prostate cancer, how effective are drugs or nutritional supplements in reducing the risk of prostate cancer and prostate cancer-related death? Lifestyle modification and population screening strategies were not reviewed.

pdf download Summary (PDF) (216.94 KB)
pdf download Full Report (PDF) (1.23 MB)